News Results
There are 123,586 News Results
Jul 21, 2025
-- The Ether Machine expected to launch with over 400,000 Ether ("ETH") and manage the largest pool of assets in a public vehicle for pure-play institutional-grade exposure to Ethereum and...
Jul 21, 2025
PUNE, India, July 21, 2025 /PRNewswire/ -- The Managed Services Market is poised for substantial growth, with its value projected to increase from USD 335,320 million in 2024 to USD...
Jul 23, 2025
MEXICO CITY, July 23, 2025 /PRNewswire/ -- Grupo Rotoplas S.A.B. de C.V. (BMV: AGUA*) ("Rotoplas", "the Company"), the leading provider of water solutions in the Americas, today reports its unaudited...
Jul 31, 2025
CytoSorbents highlights the vital and evolving role of CytoSorb® in the treatment of sepsis and septic shock ahead of its World Sepsis Day Global Webinar on September 10(th)
Aug 1, 2025
Interface, Inc. (Nasdaq: TILE), a worldwide commercial flooring company and global leader in sustainability, today announced results for the second quarter ended June 29, 2025. Second quarter highlights (all comparisons...
Aug 1, 2025
Delivered industry-leading total Mobile and Fixed customer growth of 198,000, driven by strong demand for our superior bundled services and strategic expansion of TELUS PureFibre connectivity
Aug 8, 2025
Grove Collaborative Holdings, Inc. (NYSE: GROV) (“Grove” or “the Company”), the world’s first plastic neutral retailer, a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation, today...
Aug 8, 2025
Geospace Technologies Corporation (NASDAQ: GEOS) (“the “Company") today announced results for its third quarter ended June 30, 2025. For the three-months ended June 30, 2025, Geospace reported revenue of $24.8...
Aug 13, 2025
Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced its financial results for the second quarter ended June 30, 2025. “Our results once again reflect resilience...
Aug 13, 2025
$10 million two-times over-subscribed rights offering creates cash runway to anticipated FDA marketing authorization decision for ProSense® in women aged 70+ with early-stage low risk breast cancer
